Imperial College London

Dr Samuel Turton

Faculty of MedicineDepartment of Medicine

Clinical Research Fellow
 
 
 
//

Contact

 

s.turton

 
 
//

Location

 

Burlington DanesHammersmith Campus

//

Summary

 

Summary

Dr. Samuel Turton is a MRC MARC clinical fellow completing a PhD in the Centre for Neuropsychopharmacology under the supervision of Prof Anne Lingford-Hughes and Prof David Nutt.

His research uses PET and MRI imaging to investigate the endogenous GABA and opioid neurotransmitter systems in alcohol addiction.

He is also involved in a number of other studies including the validation of a novel Imadazoline-2 binding site PET tracer BU99008.

Publications

Journals

Turton SP, Myers JFM, Mick IM, et al., Blunted Endogenous Opioid Release Following an Oral Dexamphetamine Challenge in Abstinent Alcohol Dependent Individuals, Molecular Psychiatry, ISSN:1359-4184

Tyacke RJ, Myers JFM, Venkataraman A, et al., 2018, Evaluation of 11C-BU99008, a positron emission tomography ligand for the Imidazoline2 binding site in human brain., J Nucl Med

Wall JSS, Iqbal J, Andrews M, et al., 2017, Development and validation of a clinical risk score to predict mortality after percutaneous coronary intervention., Open Heart, Vol:4, ISSN:2053-3624

Nahar LK, Cordero RE, Nutt D, et al., 2016, Validated Method for the Quantification of Baclofen in Human Plasma Using Solid-Phase Extraction and Liquid Chromatography-Tandem Mass Spectrometry, Journal of Analytical Toxicology, Vol:40, ISSN:0146-4760, Pages:117-123

Turton S, Lingford-Hughes A, 2016, Neurobiology and principles of addiction and tolerance, Medicine (united Kingdom), Vol:44, ISSN:1357-3039, Pages:693-696

More Publications